Sarepta Therapeutics, Inc. (SRPT) Executive Compensation
Sarepta Therapeutics, Inc. (SRPT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SRPT
CIK: 873303
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerStephen Briggs
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-23 | 2026-09-23 | 8-K | 0001193125-26-399416 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-04 | 4 | 0001193125-26-385545 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-04 | 4 | 0001193125-26-385544 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-04 | 4 | 0001193125-26-385541 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-04 | 4 | 0001193125-26-385536 | View SEC Doc Filr Page |
| 13F-HR | 2026-08-14 | 2026-06-30 | 13F-HR Filing | 0001193125-26-349827 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001167557-26-000214 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000537 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001193125-26-335056 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001193125-26-335003 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-31 | — | SCHEDULE 13G/A Filing | 0002100121-26-001000 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-30 | — | SCHEDULE 13G/A Filing | 0002012383-26-003144 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-28 | 4 | 0001193125-26-324445 | View SEC Doc Filr Page |
| 3 | 2026-07-29 | 2026-07-28 | 3 | 0001193125-26-324437 | View SEC Doc Filr Page |
| S-8 | 2026-07-28 | — | S-8 | 0001193125-26-321255 | View SEC Doc Filr Page |
| 8-K | 2026-07-27 | 2026-07-23 | 8-K | 0001193125-26-316995 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-260263 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-260261 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-260259 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-260257 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-260255 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-260250 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-260246 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-260245 | View SEC Doc Filr Page |
| S-8 | 2026-06-04 | — | S-8 | 0001193125-26-257643 | View SEC Doc Filr Page |